Aimed at helping laboratories validate their in-house COVID-19 assays, Bio-Rad Laboratories (NYSE:BIO) has launched a SARS-CoV-2 Standard containing synthetic COVID-19 RNA transcripts and human genomic DNA.
The standard allows labs to test the entire
process of a molecular assay, including extraction, amplification and
virus detection.
https://seekingalpha.com/news/3551446-bio-rad-launches-coronavirus-standard
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.